McCormick & Company Incorporated (MKC)
Official siteCONSUMER DEFENSIVE • PACKAGED FOODS • NYSE
Market Cap: $12.64B
Last updated: Nov 17, 2026 at 11:06 AM ET
McCormick & Company Incorporated (MKC) Stock Forecast
Analysts expect McCormick & Company (MKC) to earn $3.08 per share in the fiscal year ending Nov 30, 2026, on revenue of $7.93B. Of 15 analysts, 7 rate the stock Buy or Strong Buy, 8 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 3 estimates for the fiscal year ending Nov 30, 2026 were revised up and 3 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 15 ratings average 2.33, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 47% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 3 | 20.0% |
| Buy | 4 | 26.7% |
| Hold | 8 | 53.3% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 15
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 4.2% and revenue estimates rise 2.8%.
- Fiscal year ending Nov 30, 2026
- $3.08
- EPS consensus, revenue $7.93B
- Fiscal year ending Nov 30, 2027
- $3.21
- EPS consensus, revenue $8.15B
- Next report
- Jan 20, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Nov 30, 2026 | $3.08 | $3.00 to $3.11 | 14 | $7.93B | $7.78B to $7.98B | 15 |
| Nov 30, 2027 | $3.21 | $3.12 to $3.42 | 12 | $8.15B | $8.06B to $8.31B | 11 |
Quarterly Estimates
The EPS consensus falls from $0.79 for the quarter ending Nov 30, 2026 to $0.64 for the quarter ending Feb 28, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Nov 30, 2026 | $0.79 | $0.74 to $0.90 | 13 | $2.13B | $2.03B to $2.25B | 13 |
| Feb 28, 2027 | $0.64 | $0.61 to $0.66 | 4 | $1.96B | $1.95B to $1.98B | 4 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 4 upward and 15 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Nov 30, 2026 | 3 | 3 |
| Fiscal year ending Nov 30, 2027 | 1 | 9 |
| Quarter ending Feb 28, 2027 | 0 | 3 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Nov 30, 2026 has fallen 0.3% from $3.09.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Nov 30, 2026 | $3.08 | $3.09 | $3.09 | $3.09 | $3.09 | -0.2% |
| Fiscal year ending Nov 30, 2027 | $3.21 | $3.22 | $3.22 | $3.30 | $3.30 | -2.7% |
| Quarter ending Feb 28, 2027 | $0.64 | $0.67 | $0.67 | $0.67 | $0.67 | -4.3% |
Frequently Asked Questions About MKC
What is the MKC stock forecast?
Consensus analyst estimates put McCormick & Company's EPS at $3.08 for the fiscal year ending Nov 30, 2026, on revenue of $7.93B. The consensus rating from 15 analysts is Buy.
How do analysts rate MKC stock?
Of 15 analysts covering McCormick & Company, 3 rate it Strong Buy, 4 Buy, 8 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from MKC next year?
For the fiscal year ending Nov 30, 2026, the consensus EPS estimate is $3.08, with estimates from $3.00 to $3.11 from 14 analysts. For the fiscal year ending Nov 30, 2027, the consensus EPS estimate is $3.21, with estimates from $3.12 to $3.42 from 12 analysts.
What revenue do analysts expect from McCormick & Company next year?
For the fiscal year ending Nov 30, 2026, the consensus revenue estimate is $7.93B, with estimates from $7.78B to $7.98B. For the fiscal year ending Nov 30, 2027, the consensus revenue estimate is $8.15B, with estimates from $8.06B to $8.31B.
How many analysts cover MKC?
15 analysts rate McCormick & Company stock, and 14 analysts estimate its EPS for the fiscal year ending Nov 30, 2026.
MKC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors